Display options
Cite
Bateson MC, Ross PE, Murison J, et al. Ursodeoxycholic acid therapy and biliary lipids--a dose-response study. Gut. 1980;21(4):305-10doi: 10.1136/gut.21.4.305.
Bateson, M. C., Ross, P. E., Murison, J., Saunders, J. H., & Bouchier, I. A. (1980). Ursodeoxycholic acid therapy and biliary lipids--a dose-response study. Gut, 21(4), 305-10. https://doi.org/10.1136/gut.21.4.305
Bateson, M C, et al. "Ursodeoxycholic acid therapy and biliary lipids--a dose-response study." Gut vol. 21,4 (1980): 305-10. doi: https://doi.org/10.1136/gut.21.4.305
Bateson MC, Ross PE, Murison J, Saunders JH, Bouchier IA. Ursodeoxycholic acid therapy and biliary lipids--a dose-response study. Gut. 1980 Apr;21(4):305-10. doi: 10.1136/gut.21.4.305. PMID: 7429292; PMCID: PMC1419617.
Copy Download .nbib Format: NLM
Share it on
Full text links
HighWire Free PMC Article

Gut. 1980 Apr;21(4):305-10. doi: 10.1136/gut.21.4.305.

Ursodeoxycholic acid therapy and biliary lipids--a dose-response study.

Gut

M C Bateson, P E Ross, J Murison, J H Saunders, I A Bouchier

PMID: 7429292 PMCID: PMC1419617 DOI: 10.1136/gut.21.4.305
Free PMC Article

Abstract

The effects of four different doses of ursodeoxycholic acid (250, 500, 750, and 1000 mg daily) on biliary lipids were studied in 24 patients with radiolucent gallbladder stones. There was a significant increase in the proportion of ursodeoxycholic acid in bile after all doses, being greatest with 750 and 1000 mg daily. Unsulphated lithocholic acid was also increased in the bile after therapy, while the other major bile acids were reduced. The cholesterol content of bile was reduced by all doses, and this change was most marked after 1000 mg (from 10.9 +/- 1.4 to 5.6 +/- 0.5 mol%, P < 0.01). Biliary cholesterol saturation improved significantly only after 750 and 1000 mg daily.

References

  1. Medicine (Baltimore). 1966 Nov;45(6):461-70 - PubMed
  2. J Clin Invest. 1968 May;47(5):1043-52 - PubMed
  3. N Engl J Med. 1971 Jan 28;284(4):177-81 - PubMed
  4. Z Ernahrungswiss. 1971 Apr;10(3):223-33 - PubMed
  5. J Clin Invest. 1973 Jun;52(6):1467-79 - PubMed
  6. Gastroenterology. 1973 Oct;65(4):698-700 - PubMed
  7. Am J Dig Dis. 1974 Oct;19(10):877-86 - PubMed
  8. N Engl J Med. 1975 Aug 21;293(8):378-83 - PubMed
  9. Clin Chim Acta. 1976 Apr 15;68(2):159-66 - PubMed
  10. Gastroenterol Jpn. 1976;11(2):111-5 - PubMed
  11. Nihon Shokakibyo Gakkai Zasshi. 1976 Oct;73(10):1232-46 - PubMed
  12. Gut. 1977 Aug;18(8):599-605 - PubMed
  13. Lancet. 1977 Aug 20;2(8034):367-9 - PubMed
  14. Gastroenterology. 1977 Nov;73(5):1131-7 - PubMed
  15. Gastroenterology. 1978 Jan;74(1):75-81 - PubMed
  16. Minerva Med. 1977 Oct 17;68(49):3355-82 - PubMed
  17. Lancet. 1977 Dec 24-31;2(8052-8053):1297-301 - PubMed
  18. JAMA. 1978 Mar 13;239(11):1041-6 - PubMed
  19. JAMA. 1978 Mar 20;239(12):1138-44 - PubMed
  20. Gastroenterol Jpn. 1977;12(6):469-75 - PubMed
  21. Lancet. 1978 May 27;1(8074):1111-4 - PubMed
  22. J Clin Invest. 1978 Apr;61(4):998-1026 - PubMed
  23. J Lipid Res. 1978 Aug;19(6):723-8 - PubMed
  24. Gastroenterology. 1978 Dec;75(6):1016-20 - PubMed
  25. J Lipid Res. 1978 Nov;19(8):945-55 - PubMed
  26. Br Med J. 1979 Jan 6;1(6155):24 - PubMed
  27. Gut. 1979 Apr;20(4):312-7 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources